AU5250400A - Osteogenesis promoters - Google Patents

Osteogenesis promoters

Info

Publication number
AU5250400A
AU5250400A AU52504/00A AU5250400A AU5250400A AU 5250400 A AU5250400 A AU 5250400A AU 52504/00 A AU52504/00 A AU 52504/00A AU 5250400 A AU5250400 A AU 5250400A AU 5250400 A AU5250400 A AU 5250400A
Authority
AU
Australia
Prior art keywords
osteogenesis promoters
osteogenesis
promoters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52504/00A
Inventor
Kazuyuki Itoh
Hideki Yoshikawa
Kiyoko Yoshioka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide Corp filed Critical Welfide Corp
Publication of AU5250400A publication Critical patent/AU5250400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
AU52504/00A 1999-06-18 2000-06-16 Osteogenesis promoters Abandoned AU5250400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP17233099 1999-06-18
JP11/172330 1999-06-18
PCT/JP2000/003969 WO2000078351A1 (en) 1999-06-18 2000-06-16 Osteogenesis promoters

Publications (1)

Publication Number Publication Date
AU5250400A true AU5250400A (en) 2001-01-09

Family

ID=15939915

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52504/00A Abandoned AU5250400A (en) 1999-06-18 2000-06-16 Osteogenesis promoters

Country Status (2)

Country Link
AU (1) AU5250400A (en)
WO (1) WO2000078351A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5042419B2 (en) * 2001-08-15 2012-10-03 旭化成ファーマ株式会社 Bone formation promoter and composition for promoting bone formation
US7645878B2 (en) 2002-03-22 2010-01-12 Bayer Healthcare Llc Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
JP4895219B2 (en) * 2005-02-16 2012-03-14 アステラス製薬株式会社 Pain treatment agent containing ROCK inhibitor
KR20080040027A (en) 2005-09-02 2008-05-07 아스테라스 세이야쿠 가부시키가이샤 Amide derivatives as rock inhibitors
JPWO2010058679A1 (en) * 2008-11-18 2012-04-19 国立大学法人九州大学 Fracture repair accelerator
JP6189581B2 (en) 2009-02-20 2017-08-30 セルラー ダイナミクス インターナショナル， インコーポレイテッド Methods and compositions for stem cell differentiation
WO2010099539A1 (en) 2009-02-27 2010-09-02 Cellular Dynamics International, Inc. Differentiation of pluripotent cells
BR112012008848A2 (en) 2009-10-16 2019-09-24 Scripps Research Inst in vitro or ex vivo method for inducing non-pluripotent mammalian cells into induced pluripotent stem cells
WO2012087965A2 (en) 2010-12-22 2012-06-28 Fate Therapauetics, Inc. Cell culture platform for single cell sorting and enhanced reprogramming of ipscs
GB201107176D0 (en) 2011-04-28 2011-06-15 Cxr Biosciences Ltd Pyrrolnitrin derivatives
AU2013251785B2 (en) 2012-04-24 2018-05-10 Dan S. Kaufman Method for developing natural killer cells from stem cells
CN113564124A (en) 2013-03-14 2021-10-29 加利福尼亚大学董事会 In vitro generation of medial ganglionic eminence precursor cells
EP3114214B1 (en) 2014-03-04 2023-11-01 Fate Therapeutics, Inc. Improved reprogramming methods and cell culture platforms
EP4088719A1 (en) 2015-10-13 2022-11-16 Institut National de la Santé et de la Recherche Médicale (INSERM) Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion
WO2017064119A1 (en) 2015-10-13 2017-04-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion
CN117737124A (en) 2015-10-16 2024-03-22 菲特治疗公司 Platform for inducing and maintaining ground state pluripotency
RU2628370C2 (en) * 2015-12-28 2017-08-16 Федеральное государственное бюджетное учреждение "Центральный научно-исследовательский институт травматологии и ортопедии имени Н.Н. Приорова" Министерства здравоохранения Российской Федерации (ФГБУ "ЦИТО им. Н.Н. Приорова" Минздрава России) Method for heterotopic ossification surgical treatment with local neural simulation of spastic syndrome
WO2020193802A1 (en) 2019-03-28 2020-10-01 Fundación De La Comunidad Valenciana Centro De Investigación Príncipe Felipe Polymeric conjugates and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550134A (en) * 1995-05-10 1996-08-27 Eli Lilly And Company Methods for inhibiting bone loss
JPH11514361A (en) * 1995-10-16 1999-12-07 藤沢薬品工業株式会社 Heterocyclic compounds as H + -ATPase
EA199800393A1 (en) * 1995-10-23 1998-12-24 Займодженетикс, Инк. COMPOSITIONS AND METHODS OF THEIR APPLICATION FOR THE TREATMENT OF DAMAGE OF BONES
DK0956865T4 (en) * 1996-08-12 2010-11-22 Mitsubishi Tanabe Pharma Corp Medications comprising Rho kinase inhibitor
EP0973513A4 (en) * 1996-10-23 2003-03-19 Zymogenetics Inc Compositions and methods for treating bone deficit conditions

Also Published As

Publication number Publication date
WO2000078351A1 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
AU5489099A (en) Seed-preferred promoters
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU2001271434A1 (en) Novel skateboard-bicycle combination
AU5250400A (en) Osteogenesis promoters
AU6865100A (en) Osteogenesis promoting agents
AU2829600A (en) Osteogenesis promoters
AU2719500A (en) Seed-preferred promoter
AU4115400A (en) Short-circuiter
AU2804600A (en) Arylaminoalkylamides
AU2023701A (en) Sketcher
AU1887400A (en) Adhesion promoters
AU3968100A (en) Fixture unit
AU2699800A (en) Organoceramics
AU5824400A (en) Vascular-specific promoters
AU4916900A (en) Benzofuranylsulfonates
AU2359301A (en) Novel ss-defensins
AU7273000A (en) Novel processes
AU4561600A (en) Benzofuranylaminoalcohols
AU2001260643A1 (en) Ectocornea extension promoters
AU1038501A (en) Novel processes
AU4597100A (en) Senescence-related promoters
AU1901801A (en) Glucofuranoses
AU2939100A (en) Promoters
AU2273500A (en) Hand controller

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase